{"canonical":"https://abierto.us/vendors/starks-associates-inc-day5fjmyl4l8","key":"DAY5FJMYL4L8","name":"STARKS ASSOCIATES INC.","uei":"DAY5FJMYL4L8","city":"BUFFALO","state":"NY","awards":1,"obligated":"-153087.36","notices_won":0,"top_agency_name":"National Institutes of Health","top_naics":"541712","cage":"6R012","parent_name":"STARKS ASSOCIATES INC.","also_known_as":[],"country":"USA","actions":2,"first_action":"2025-03-27","last_action":"2026-09-04","breakdowns":{"naics":[{"key":"541712","name":null,"awards":1,"obligated":"-153087.36"}],"places":[{"key":"NY","name":null,"awards":1,"obligated":"-153087.36"}],"agencies":[{"key":"7529","name":"National Institutes of Health","awards":1,"obligated":"-153087.36"}],"set_asides":[{"key":"SMALL BUSINESS SET ASIDE - TOTAL","name":null,"awards":1,"obligated":"-153087.36"}],"award_types":[{"key":"DEFINITIVE CONTRACT","name":null,"awards":1,"obligated":"-153087.36"}],"competition":[{"key":"FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES","name":null,"awards":1,"obligated":"-153087.36"}],"product_service_codes":[{"key":"AN81","name":null,"awards":1,"obligated":"-153087.36"}]},"awards_list":[{"award_key":"CONT_AWD_75N93024F00001_7529_75N93021D00005_7529","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N93024F00001_7529_75N93021D00005_7529/","piid":"75N93024F00001","parent_piid":"75N93021D00005","award_type":"DELIVERY ORDER","vendor_key":"DAY5FJMYL4L8","recipient_name":"STARKS ASSOCIATES INC.","recipient_uei":"DAY5FJMYL4L8","recipient_cage":"6R012","recipient_city":"BUFFALO","recipient_state":"NY","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NIAID","office_key":"o-75N930","first_action_date":"2024-03-21","last_action_date":"2024-03-21","actions":1,"obligated":"1264071.00","current_total_value":"1264071.00","potential_total_value":"1264071.00","naics":"541715","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":null,"offers_received":2,"description":"CONDUCT SYNTHESIS AND ACQUIRE BATCHES OF COMPOUNDS FOR SUBSEQUENT BIOLOGICAL IN VITRO AND IN VIVO TESTING","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_IDV_75N93021D00005_7529","permalink":"https://www.usaspending.gov/award/CONT_IDV_75N93021D00005_7529/","piid":"75N93021D00005","parent_piid":null,"award_type":null,"vendor_key":"DAY5FJMYL4L8","recipient_name":"STARKS ASSOCIATES INC.","recipient_uei":"DAY5FJMYL4L8","recipient_cage":"6R012","recipient_city":"BUFFALO","recipient_state":"NY","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NIAID","office_key":"o-75N930","first_action_date":"2024-11-29","last_action_date":"2024-11-29","actions":1,"obligated":"0","current_total_value":null,"potential_total_value":"107274471.00","naics":"541715","psc":"AN81","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":4,"description":"THE CONTRACTOR SHALL PROVIDE PRECLINICAL DEVELOPMENT SUPPORT FOR CANDIDATE PRODUCTS AND DRUG DEVELOPMENT ACTIVITIES.","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_HHSN272201500003C_7529_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_HHSN272201500003C_7529_-NONE-_-NONE-/","piid":"HHSN272201500003C","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"DAY5FJMYL4L8","recipient_name":"STARKS ASSOCIATES INC.","recipient_uei":"DAY5FJMYL4L8","recipient_cage":"6R012","recipient_city":"BUFFALO","recipient_state":"NY","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NIAID","office_key":"o-75N930","first_action_date":"2024-05-08","last_action_date":"2026-09-04","actions":3,"obligated":"-203920.18","current_total_value":"8025497.50","potential_total_value":"8025497.50","naics":"541712","psc":"AN81","extent_competed":"FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES","set_aside":"SMALL BUSINESS SET ASIDE - TOTAL","offers_received":2,"description":"SYNTHESIS OF THERAPEUTIC AGENTS FOR TREATMENT OF INFECTIOUS DISEASES","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null}],"awards_total":3,"awards_page":1,"won":[],"won_total":0,"solicitations_won":[]}